Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017102

CHIEF BUSINESS OFFICER acquired 102,519 shares (grant or award)

  • CHIEF BUSINESS OFFICER acquired 16,354,961 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Saund Saran · CHIEF BUSINESS OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 1 in the form +16,354,961 16,354,961 D
2021-07-08 Grant or award : show line 2 in the form +102,519 16,457,480 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-03-31 Conversion : show line 3 in the form Series A Convertible Preferred Stock −16,355 0 D
2021-07-08 Grant or award : show line 4 in the form Stock Options +216,279 216,279 D
Loading xslF345X03/ownership.xml…